Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019
| Autor: | Razonable, Raymund R., O’Horo, John C., Challener, Douglas W., Arndt, Lori, Arndt, Richard F., Clune, Caroline G., Culbertson, Tracy L., Hall, Scott T., Heyliger, Alexander, Jackson, Tammy A., Kennedy, Brian D., Larsen, Jennifer, Hanson, Sara N., Sweeten, Perry W., Tulledge-Scheitel, Sidna M., Ganesh, Ravindra |
|---|---|
| Zdroj: | In Mayo Clinic Proceedings September 2022 97(9):1641-1648 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|